Myocardial 2D strain echocardiography and cardiac biomarkers in children during and shortly after anthracycline therapy for acute lymphoblastic leukaemia (ALL): a prospective study.
暂无分享,去创建一个
Ton Feuth | Livia Kapusta | Chris L de Korte | C. D. de Korte | T. Feuth | P. Hoogerbrugge | A. Mavinkurve-Groothuis | L. Kapusta | Peter M Hoogerbrugge | Annelies M C Mavinkurve-Groothuis | Karen A Marcus | K. Marcus | M. Pourier | J. Loonen | Milanthy Pourier | Jacqueline Loonen | K. A. Marcus | A. Mavinkurve‐Groothuis
[1] E J Orav,et al. Female sex and higher drug dose as risk factors for late cardiotoxic effects of doxorubicin therapy for childhood cancer. , 1995, The New England journal of medicine.
[2] C. D. de Korte,et al. Interobserver, intraobserver and intrapatient reliability scores of myocardial strain imaging with 2-d echocardiography in patients treated with anthracyclines. , 2009, Ultrasound in medicine & biology.
[3] J. Cleland,et al. Association of galectin‐3 and fibrosis markers with long‐term cardiovascular outcomes in patients with heart failure, left ventricular dysfunction, and dyssynchrony: insights from the CARE‐HF (Cardiac Resynchronization in Heart Failure) trial , 2012, European journal of heart failure.
[4] N Reichek,et al. Echocardiographic Determination of Left Ventricular Mass in Man: Anatomic Validation of the Method , 1977, Circulation.
[5] Shinobu Nakamura,et al. Brain Natriuretic Peptide Is a Predictor of Anthracycline-Induced Cardiotoxicity , 2001, Acta Haematologica.
[6] S. Colan,et al. A Novel Method of Expressing Left Ventricular Mass Relative to Body Size in Children , 2007, Circulation.
[7] R. Murphy,et al. Subclinical anthracycline- and trastuzumab-induced cardiotoxicity in the long-term follow-up of asymptomatic breast cancer survivors: a speckle tracking echocardiographic study , 2010, Heart.
[8] T. Feuth,et al. Abnormal NT‐pro‐BNP levels in asymptomatic long‐term survivors of childhood cancer treated with anthracyclines , 2008, Pediatric blood & cancer.
[9] C. Wippermann,et al. Normal values of M mode echocardiographic measurements of more than 2000 healthy infants and children in central Europe , 2000, Heart.
[10] J D'hooge,et al. The relative value of strain and strain rate for defining intrinsic myocardial function. , 2012, American journal of physiology. Heart and circulatory physiology.
[11] J. Seward,et al. Diastolic ventricular function in children: a Doppler echocardiographic study establishing normal values and predictors of increased ventricular end-diastolic pressure. , 1998, Mayo Clinic proceedings.
[12] K. Hallermayer,et al. Use of recombinant human cardiac Troponin T for standardization of third generation Troponin T methods. , 1999, Scandinavian journal of clinical and laboratory investigation. Supplementum.
[13] R. Nagai,et al. Elevated B-type natriuretic peptide levels after anthracycline administration. , 1998, American heart journal.
[14] J. Krischer,et al. Clinical cardiotoxicity following anthracycline treatment for childhood cancer: the Pediatric Oncology Group experience. , 1997, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[15] J. Bryant,et al. Use of cardiac markers to assess the toxic effects of anthracyclines given to children with cancer: a systematic review. , 2007, European journal of cancer.
[16] Randolph P. Martin,et al. Assessment of Echocardiography and Biomarkers for the Extended Prediction of Cardiotoxicity in Patients Treated With Anthracyclines, Taxanes, and Trastuzumab , 2012, Circulation. Cardiovascular imaging.
[17] Piet Claus,et al. Acute cardiac functional and morphological changes after Anthracycline infusions in children. , 2007, The American journal of cardiology.
[18] J. Horáček,et al. The use of biochemical markers in cardiotoxicity monitoring in patients treated for leukemia. , 2004, Neoplasma.
[19] J. Cohn,et al. Prognostic Value of Very Low Plasma Concentrations of Troponin T in Patients With Stable Chronic Heart Failure , 2007, Circulation.
[20] William Stewart,et al. Recommendations for chamber quantification. , 2006, European journal of echocardiography : the journal of the Working Group on Echocardiography of the European Society of Cardiology.
[21] P. Harst,et al. The fibrosis marker galectin‐3 and outcome in the general population , 2012, Journal of internal medicine.
[22] C. D. de Korte,et al. Reference values for myocardial two-dimensional strain echocardiography in a healthy pediatric and young adult cohort. , 2011, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.
[23] G. Nesbitt,et al. Strain and Strain Rate Imaging in Cardiomyopathy , 2009, Echocardiography.
[24] W. Kamps,et al. Long-term results of Dutch Childhood Oncology Group studies for children with acute lymphoblastic leukemia from 1984 to 2004 , 2010, Leukemia.
[25] Randolph P. Martin,et al. Early detection and prediction of cardiotoxicity in chemotherapy-treated patients. , 2011, The American journal of cardiology.
[26] A. Tiran,et al. Prolonged monitoring of troponin T for the detection of anthracycline cardiotoxicity in adults with hematological malignancies , 2003, Annals of Hematology.
[27] P. Sengupta,et al. Two-dimensional strain--a Doppler-independent ultrasound method for quantitation of regional deformation: validation in vitro and in vivo. , 2005, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.
[28] A. Wolff,et al. Troponins for predicting cardiotoxicity from cancer therapy , 2000, The Lancet.
[29] M. Panteghini,et al. Biochemical markers for prediction of chemotherapy-induced cardiotoxicity: systematic review of the literature and recommendations for use. , 2008, American journal of clinical pathology.
[30] J. Potter,et al. Late mortality experience in five-year survivors of childhood and adolescent cancer: the Childhood Cancer Survivor Study. , 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[31] P. Poole‐Wilson,et al. Value of natriuretic peptides in assessment of patients with possible new heart failure in primary care , 1997, The Lancet.
[32] S. Colan,et al. Late cardiac effects of doxorubicin therapy for acute lymphoblastic leukemia in childhood. , 1991, The New England journal of medicine.
[33] M. Quiñones,et al. Doppler tissue imaging: a noninvasive technique for evaluation of left ventricular relaxation and estimation of filling pressures. , 1997, Journal of the American College of Cardiology.
[34] Mario J. Garcia,et al. Doppler-Derived Myocardial Systolic Strain Rate Is a Strong Index of Left Ventricular Contractility , 2002, Circulation.
[35] M. Cerqueira,et al. Standardized myocardial segmentation and nomenclature for tomographic imaging of the heart. A statement for healthcare professionals from the Cardiac Imaging Committee of the Council on Clinical Cardiology of the American Heart Association. , 2002, Circulation.
[36] S. Ha,et al. Left ventricular myocardial deformation and mechanical dyssynchrony in children with normal ventricular shortening fraction after anthracycline therapy , 2010, Heart.
[37] T. Mir,et al. N-Terminal pro-brain natriuretic peptide: normal ranges in the pediatric population including method comparison and interlaboratory variability , 2006, Clinical chemistry and laboratory medicine.
[38] S. Lipsitz,et al. Chronic progressive cardiac dysfunction years after doxorubicin therapy for childhood acute lymphoblastic leukemia. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[39] S. Lipshultz,et al. Protecting against anthracycline‐induced myocardial damage: a review of the most promising strategies , 2005, British journal of haematology.
[40] A. Mavinkurve-Groothuis,et al. THE ROLE OF BIOMARKERS IN THE EARLY DETECTION OF ANTHRACYCLINE-INDUCED CARDIOTOXICITY IN CHILDREN: A Review of the Literature , 2008, Pediatric hematology and oncology.
[41] Zvi Vered,et al. Two-dimensional strain-a novel software for real-time quantitative echocardiographic assessment of myocardial function. , 2004, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.
[42] W. Kamps,et al. Low-dose daunorubicin in induction treatment of childhood acute lymphoblastic leukemia: no long-term cardiac damage in a randomized study of the Dutch Childhood Leukemia Study Group. , 2000, Medical and pediatric oncology.
[43] Left ventricular dysfunction predicted by early troponin I release after high-dose chemotherapy. , 2000, Journal of the American College of Cardiology.
[44] S. Fosså,et al. Left ventricular function assessed by two-dimensional speckle tracking echocardiography in long-term survivors of Hodgkin's lymphoma treated by mediastinal radiotherapy with or without anthracycline therapy. , 2011, The American journal of cardiology.
[45] Ton Feuth,et al. Myocardial strain and strain rate in monitoring subclinical heart failure in asymptomatic long-term survivors of childhood cancer. , 2010, Ultrasound in medicine & biology.
[46] E. Bonifacio,et al. Novel organ-specific circulating cardiac autoantibodies in dilated cardiomyopathy. , 1990, Journal of the American College of Cardiology.